S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

10x Genomics Sets November 5 Date for Third Quarter Results

Pleasanton-based biotechnology firm 10x Genomics will disclose its financial performance for the third quarter of 2026 on November 5. The company intends to release its earnings statement after the close of the market, followed by a live conference call to outline recent business developments and forward-looking projections.

10x Genomics Sets November 5 Date for Third Quarter Results
Photo: Bio & News

Management will host a public webcast at 1:30 p.m. Pacific Time to discuss the results with analysts and investors. Interested parties can access the audio stream and supplemental materials through the company’s investor relations portal. The recording will remain available for replay for a minimum of 45 days following the broadcast.

10x Genomics continues to focus on single-cell and spatial biology, providing hardware and software tools to researchers in oncology, immunology, and neuroscience. The firm maintains its standard disclosure practices, utilizing its official website and SEC filings to communicate material information to shareholders.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!